Literature DB >> 16736447

Mixed acid-base disturbances.

H J Adrogué1.   

Abstract

Mixed acid-base disturbances, defined as the simultaneous presence of two or more acid-base disorders, are commonly observed in hospitalized patients, especially those in critical care units. Certain clinical settings are commonly associated with mixed acid-base disorders, including cardiorespiratory arrest, sepsis, drug intoxications, diabetes mellitus, and organ failure (especially renal, hepatic, and pulmonary failure). As a general rule, the symptoms and signs of the underlying disease that gives rise to the observed mixed acid-base disorder dominate the clinical picture. The basic principles underlying the diagnosis of mixed acid-base disorders are identical to those required for the identification of simple acid-base disturbances. The management of mixed acid-base disturbances is aimed at restoring the altered acid-base status by reversing all the elemental components present, thus it encompasses the therapy of each simple acid-base disorder.

Entities:  

Mesh:

Year:  2006        PMID: 16736447

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  3 in total

1.  Prevention of acute kidney injury by intravenous sodium bicarbonate: the end of a saga.

Authors:  Helmut Schiffl
Journal:  Crit Care       Date:  2014-11-27       Impact factor: 9.097

2.  Effect of perioperative sodium bicarbonate administration on renal function following cardiac surgery for infective endocarditis: a randomized, placebo-controlled trial.

Authors:  Jin Sun Cho; Sarah Soh; Jae-Kwang Shim; Sanghwa Kang; Haegi Choi; Young-Lan Kwak
Journal:  Crit Care       Date:  2017-01-05       Impact factor: 9.097

3.  A novel scoring system for assessing the severity of electrolyte and acid-base disorders and predicting outcomes in hospitalized patients.

Authors:  Yimei Wang; Jiachang Hu; Xuemei Geng; Xiaoyan Zhang; Xialian Xu; Jing Lin; Jie Teng; Xiaoqiang Ding
Journal:  J Investig Med       Date:  2018-12-06       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.